← Open Payments lookup

LAWRENCE YOUNG: Open Payments

NPI 1568444388 · COMMERCE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 46 payments from 17 companies in 2025. Trend: 2023 $844 · 2024 $1,039 · 2025 $870

Food & beverage: $870
CompanyPaymentsAmount
ABBVIE INC.8$195
GlaxoSmithKline, LLC.6$109
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$101
PFIZER INC.3$75
Novo Nordisk Inc4$70
AstraZeneca Pharmaceuticals LP4$69
Teva Pharmaceuticals USA, Inc.3$52
Otsuka America Pharmaceutical, Inc.2$38
Aimmune Therapeutics, Inc.1$28
Lundbeck LLC1$22

Products named: VRAYLAR, TRELEGY ELLIPTA, CAPLYTA, ELIQUIS, REXULTI, BREZTRI, AUSTEDO XR, Ozempic.

Industry payments across TX — which companies pay providers there.